According to The Washington Post, Verizon — the nation’s largest mobile operator — is venturing into telemedicine and believes that it is a big business opportunity.
Verizon recently announced they are providing the University of Virginia and Stanford University with private network services, data center services, a private Internet cloud for patient data (among other services), for a study on “artificial pancreas” and additional clinical trials on telemedicine.
The artificial pancreas uses a series of devices along with a glucose monitor that is inserted under the skin of Type 1 diabetics. The monitor relays glucose levels to smartphones and automatically releases insulin in the body as needed.
“[Researchers] need to be able to have Internet and wireless capability, to enable data to be transferred between continuous medical devices,” said Jean McManus, Verizon’s executive director of technology. “The same closed-loop technology Verizon offers in these clinical trials — when users’ devices rely on private networks to relay data to a Verizon data center, and back — could eventually be applied outside of healthcare” she added.
Verizon is still looking for ways to commercialize the complex networks in healthcare.
McManus adds that “One of the things we really want to do is we have a suite of private network services,” for other industries beyond healthcare, including finance.